L&K Biomed Ltd. (KOSDAQ:156100)

Market Cap	307.70B
Revenue (ttm)	40.33B
Net Income (ttm)	5.84B
Shares Out	21.03M
EPS (ttm)	265.47
PE Ratio	55.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,193,196
Average Volume	840,720
Open	14,490
Previous Close	13,930
Day's Range	14,450 - 15,930
52-Week Range	5,570 - 15,500
Beta	1.53
RSI	69.46
Earnings Date	Nov 14, 2025

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2008
• Employees: 60
• Stock Exchange: KOSDAQ
• Ticker Symbol: 156100